Status:
COMPLETED
Raloxifene on Coagulation System in the Postmenopausal Women
Lead Sponsor:
Karadeniz Technical University
Conditions:
Raloxifene
Postmenopausal Women
Eligibility:
FEMALE
42-62 years
Brief Summary
Objective: The aim of this study is to assess the effects of raloxifene HCl on coagulation parameters in healthy postmenopausal women. Material and method: 80 healthy postmenopausal women were evalua...
Eligibility Criteria
Inclusion
- In the study planned on patients who have not had menstruation for at least one year, or who have been in menopause naturally or surgically,
- the presence of menopause was accepted if the patients' FSH level was\> 40 IU / L. Verbal and written consent was obtained from all patients included in the study.
Exclusion
- . Hypertension,
- diabetes mellitus,
- hypercholesterolemia,
- presence of hepatic-renal-thyroid-parathyroid-adrenal diseases,
- cardiovascular,
- cerebrovascular and thromboembolic diseases,
- undiagnosed vaginal bleeding,
- presence of hormone-dependent malignancy or anamnesis,
- presence of varicose veins,
- chronic drug use that disrupts sex steroid metabolism
- cases with smoking
- alcohol use
Key Trial Info
Start Date :
December 1 2005
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 20 2006
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT04454775
Start Date
December 1 2005
End Date
December 20 2006
Last Update
July 7 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.